Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-06-08, Stock:ABBV, The news for the past five days is as follows:
2020-06-01: NEWS1: 3 Strong Pharmaceutical and Biotech Stocks to Buy for Coronavirus Immunity.NEWS2: AbbVie Unveils Deal for Potential Tumor-Fighting Drug.NEWS3: AbbVie Gets FDA Nod for Oriahnn to Control Menstrual Bleeding.NEWS4: AbbVie Submits Regulatory Applications to FDA and EMA for RINVOQ™ (upadacitinib) for the Treatment of Adults with Active Psoriatic Arthritis.NEWS5: Lilly's Cyramza Gets FDA Approval for First-Line Lung Cancer.NEWS6: AbbVie Wrapped Its $63 Billion Allergan Buyout — Is AbbVie Stock A Buy?.NEWS7: Allergan Aesthetics Launches Dedicated Multi-Channel Campaign To Contact Patients Who May Not Be Aware Of The BIOCELL® Recall And To Improve Tracking Information For U.S. Breast Implant Patients.NEWS8: Drugmaker Abbvie Teams Up With Jacobio To Develop Cancer Inhibitor.NEWS9: AbbVie and Jacobio Announce Strategic Collaboration to Advance SHP2 Inhibitors.
2020-06-02: NEWS1: AbbVie (ABBV) Gains But Lags Market: What You Should Know.NEWS2: MARKETS: Dow surges into the close, up 268 points — YF Premium is bullish on Abbvie (ABBV).NEWS3: 7 High-Dividend Stocks With Durable Distributions.NEWS4: Biosimilars of Humira Have Saved Europe a Bundle, Study Says.NEWS5: Pharma Large And Mid-Caps Race Against COVID-19.NEWS6: AbbVie Invests in a Cancer Drug - How to Trade the Stock.NEWS7: These 2 charts show why record-high stock valuations shouldn’t worry investors.NEWS8: AbbVie Seeks US and EU Nods for Rinvoq for Psoriatic Arthritis.NEWS9: AbbVie Stock Affirmed Outperform at RBC on Allergan Potential.NEWS10: AstraZeneca Ranked Most Inventive, Roche Most Innovative.NEWS11: AbbVie Stock Has Room to Run After Allergan Merger, Argus Says.NEWS12: The Zacks Analyst Blog Highlights: Tencent, Abbvie and Reckitt Benckiser.NEWS13: Buy Lilly, AbbVie and Merck Stocks, J.P. Morgan Says, but Pfizer Is Still Expensive.NEWS14: 3 Stocks With Dividends Yielding More Than 3%.NEWS15: AbbVie Seeks Rinvoq Approval For Psoriatic Arthritis In US, Europe.NEWS16: Revance, Mylan Move Forward With Botox Rival; Analyst Sees Long Path Ahead.
2020-06-03: NEWS1: Bristol Myers' Zeposia Meet Goals in Ulcerative Colitis Study.NEWS2: Is AbbVie (ABBV) Stock Undervalued Right Now?.NEWS3: Increased Earnings Estimates Seen for AbbVie (ABBV): Can It Move Higher?.NEWS4: AbbVie to Present at the Virtual Goldman Sachs 41st Annual Global Healthcare Conference.NEWS5: Why Editas Medicine Is Now the CRISPR Stock to Really Watch.
2020-06-04: NEWS1: Is AbbVie (ABBV) Outperforming Other Medical Stocks This Year?.NEWS2: Here's The Next Catalyst For Buy Zone-Lingering Neurocrine Biosciences.NEWS3: Top Ranked Value Stocks to Buy for June 4th.NEWS4: AbbVie Follows Up After Reversal.NEWS5: Signs That Your Trading Will Ruin Your Retirement - June 04, 2020.NEWS6: New Long-term Data from RINVOQ™ (upadacitinib, 15 mg) Phase 3 Studies in Rheumatoid Arthritis Presented at 2020 Annual European E-Congress of Rheumatology (EULAR).NEWS7: 50-Day Rally Spells Good Times for Wall Street: 5 Solid Buys.NEWS8: Dr. Keshav K. Singh Joins Allergan Aesthetics Science Of Aging(SM) Faculty.
2020-06-05: NEWS1: Pharma Giant AbbVie Enters Ring With A Potential Coronavirus Treatment.NEWS2: AbbVie Enters the Race to Develop New COVID-19 Treatments.NEWS3: Biotech Stock To Watch: Why This Leader Could Be Poised For Another Run.NEWS4: The Market Timing Secrets No One Talks About - June 05, 2020.NEWS5: The Zacks Analyst Blog Highlights: AbbVie, Amkor Technology, Calix, The Hain Celestial Group and Acacia Communications.NEWS6: Pharma Stock Roundup: LLY Coronavirus Antibody Phase I Study Initiation, FDA Approvals.NEWS7: The Daily Biotech Pulse: Adamas Rallies On FDA Acceptance, Oxford Immunotech Reportedly Gets $400M Bid.NEWS8: AbbVie, Harbour BioMed, Utrecht University and Erasmus Medical Center Announce Collaboration to Develop Monoclonal Antibody Therapy to Prevent and Treat COVID-19.

Answer: Rise